Bearishness Around Pfizer Gilead Sparks Opportunity
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Unlock ways to earn travel points on no fee cards. Boost your rewards and make the most of your travel expenses effortlessly.
17,323 articlesWall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...
What counts as the ultimate “stress test” for housing in 2026? This article breaks down signals, scenarios, and pract...
A high-profile insider move can ripple through a stock's story. This article breaks down the C3.ai CEO's $4.2 million...
Palantir Technologies has had a wild ride. If you’re wondering should palantir technologies stock be bought under $14...
In the first half of 2026, Upstart stock fell about 19%, shaking confidence in a fintech darling. This article breaks...
A wave of positive economic data has the Fed blinking toward rate cuts, yet stock investors fret about what comes nex...
Toll Brothers posted a strong first quarter, underscoring resilience in the luxury segment through disciplined execut...
This article breaks down Alliant Energy's 2025 earnings outlook, capital plan, and dividend strategy. Learn what to w...
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
When a major tariff ruling shifts import costs, retail stocks can respond quickly. This article breaks down why these...
In the wake of the State Of The Union address, mortgage rates danced around 6% as markets priced in housing policy si...